AbCheck: Antibody Discovery Deal
First validation of technology and business approach
07-Oct-2010 -
AbCheck s.r.o. announced an antibody discovery deal with Eli Lilly and Company. Under the agreement, AbCheck will use its three antibody discovery libraries to deliver high-affinity, fully human antibodies against an undisclosed number of Lilly targets. The three distinct human antibody libraries ...
antigens
Eli Lilly
human antibodies
+3